succinobucol

succinobucol

An antioxidant and anti-inflammatory compound belonging to a new class of agents—composite vascular protectants—which also has potential as an anti-diabetic agent.
Mechanism
Succinobucol blocks production of certain inflammatory mediators (e.g., VCAM-1 and MCP-1), which are implicated in atherosclerosis. Succinobucol may reduce or reverse morbidity and mortality of coronary heart disease, as well as the rate of restenosis in stents.